D. Peest

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

Stefano Pasquali, J D Maqueo, Jorge Espino Vela et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1998 · 473 citations

Hematological Malignancy, Oncology, Metronomic Therapy +6

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma

Anders Österborg, MA Boogaerts, R Cimino et al. · Blood · 1996 · 206 citations · Full text

Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells

R. Leo, Martin Boeker, D. Peest et al. · Annals of Hematology · 1992 · 112 citations

Hematological Malignancy, Tumor Biology, Malignant Blood Disorder +8

T Cells in Monoclonal Gammopathies

Hákan Mellstedt, G. Holm, D Pettersson et al. · Scandinavian Journal of Haematology · 1982 · 89 citations

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +15

Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell Cancer

Anke Franzke, D. Peest, Michael Probst‐Kepper et al. · Journal of Clinical Oncology · 1999 · 88 citations